Spots Global Cancer Trial Database for Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
Official Title: Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients. A Randomised, Double-blind, Controlled Pilot Study
Study ID: NCT00851448
Study Description
Brief Summary: To test the compliance, tolerance, safety and to get preliminary insights into the efficacy of a new oral nutritional supplement (containing n-3 fatty acids, amino acids and antioxidants) designed to prevent or delay cachexia and anorexia in lung cancer patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Dipartimento di Medicina Clinica, La Sapienza Università, Rome, Rome, , Italy
Indywidualna Specjalistyczna Praktyka lekarska, Ruda Slaska, , Poland
Pulmonology Dept. of Miedzylesie Hospital, Warsaw, , Poland
Contact Details
Name: Filippo Rossi-Fanelli, Professor
Affiliation: La Sapienza Università, Rome
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
